Role(s) in Healthcare Innovation:
Concerned Citizen Designer Engineer Medical Device Industry Pro VolunteerMy Community
Global Healthcare InnovationAnne Annello
About Me
I work in Business Development and Licensing at a mid-size global company in the diabetes space. My background is in mechanical engineering, and I worked in medical device design for 7 years within the cardiology, women's health, and orthopedics industries. Almost 5 years ago, I switched to Ascensia working as a technology scout where I identified targets and evaluated technology from medical device and digital health startups to assess product functionality and fit within Ascensia. Last year I transitioned to a more commercial role, still working in the same area but focused on commercial strategy alignment and contract negotiation. I am very passionate about the potential affect products developed by companies within this organization can have on healthcare, and I would love to support.
Interested in solutions for:
For myself and those I love For my companyI am looking for healthcare innovations:
You have not backed any projects.
Lets change that!
Discover Projects
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No likes on any project yet..
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.